The significance of granuloma and amyloid deposition in primary nasopharyngeal carcinoma (NPC) has yet to be investigated. This study aimed to evaluate their clinicopathologic associations. The histopathologic findings of 747 consecutive patients with primary NPC were retrospectively reviewed between January 2001 and December 2015. The presence of granulomas and amyloid deposits was observed in 68 (9.1%) and 62 (8.3%) patients, respectively. Granulomas were significantly associated with lower T classification, N classification, and overall TNM stage (p = 0.014, p = 0.006, and p = 0.001, respectively). Their presence was an independent predictor of overall survival (p = 0.033), disease-free survival (p = 0.034), and recurrence-free survival (p = 0.040). Conversely, amyloid deposition was not a predictor in any survival analyses. The present study demonstrated the prevalence of granuloma and amyloid deposition in the largest single institution cohort of primary NPC patients so far. Our results provide evidence that granulomas are significantly associated with better prognosis and treatment outcome. Further studies are needed to elucidate the mechanism of action of granuloma formation on the anti-tumor immunity of NPC.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
The data that support the findings of this study are available on request from the corresponding author.
El-Naggar A, Chan J, Grandis J, Takata T, Slootweg P. WHO classification of head and neck tumours. Lyon: IARC; 2017.
Lee AW, Poon YF, Foo W, Law SC, Cheung FK, Chan DK, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23(2):261–70.
Chang JT, Chan SH, Lin CY, Lin TY, Wang HM, Liao CT, et al. Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15. Mol Cancer Ther. 2007;6(8):2271–9. https://doi.org/10.1158/1535-7163.MCT-06-0801.
Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol: Off J Am Soc Clin Oncol. 1998;16(4):1310–7. https://doi.org/10.1200/JCO.19220.127.116.110.
Lin JC, Jan JS, Chen KY, Hsu CY, Liang WM, Wang WY. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma. Head Neck. 2003;25(6):438–50. https://doi.org/10.1002/hed.10238.
Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, Wang WY. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol: Off J Am Soc Clin Oncol. 2003;21(4):631–7. https://doi.org/10.1200/JCO.2003.06.158.
Wockel W, Wernert N. Excessive epithelioid cell granulomatous reaction associated with a lymphoepithelial carcinoma (Schmincke-Regaud). Pathol Res Pract. 1986;181(3):349–56. https://doi.org/10.1016/S0344-0338(86)80118-2.
Chen CL, Su IJ, Hsu MM, Hsu HC. Granulomatous nasopharyngeal carcinoma: with emphasis on difficulty in diagnosis and favorable outcome. Journal of the Formos Med Assoc = Taiwan yi zhi. 1991;90(4):353–6.
Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology E-Book. Amsterdam: Elsevier Health Sciences; 2017.
Prathap K, Looi LM, Prasad U. Localized amyloidosis in nasopharyngeal carcinoma. Histopathology. 1984;8(1):27–34.
Kamiyoshihara M, Hirai T, Kawashima O, Ishikawa S, Morishita Y. Sarcoid reactions in primary pulmonary carcinoma: report of seven cases. Oncol Rep. 1998;5(1):177–80.
Diaz Del Arco C, Acenero MJ. Sarcoid reaction: a rare occurrence associated to colon adenocarcinoma (case report and literature review). J Gastrointest Oncol. 2016;7(4):E72–E7676. https://doi.org/10.21037/jgo.2016.03.07.
O'Connell MJ, Schimpff SC, Kirschner RH, Abt AB, Wiernik PH. Epithelioid granulomas in Hodgkin disease. A favorable prognostic sign? JAMA. 1975;233(8):886–9.
Sacks EL, Donaldson SS, Gordon J, Dorfman RF. Epithelioid granulomas associated with Hodgkin’s disease: clinical correlations in 55 previously untreated patients. Cancer. 1978;41(2):562–7.
Brincker H. Sarcoid reactions and sarcoidosis in Hodgkin's disease and other malignant lymphomata. Br J Cancer. 1972;26(2):120–3.
Brady G, MacArthur GJ, Farrell PJ. Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol. 2007;60(12):1397–402. https://doi.org/10.1136/jcp.2007.047977.
Bickham K, Munz C, Tsang ML, Larsson M, Fonteneau JF, Bhardwaj N, et al. EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function. J Clin Investig. 2001;107(1):121–30. https://doi.org/10.1172/JCI10209.
Finberg RW. Epstein-Barr virus-specific T cells for the management of Epstein-Barr virus lymphomas. Curr Opin Oncol. 2001;13(5):349–53.
Munz C, Bickham KL, Subklewe M, Tsang ML, Chahroudi A, Kurilla MG, et al. Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J Exp Med. 2000;191(10):1649–60.
Leen A, Meij P, Redchenko I, Middeldorp J, Bloemena E, Rickinson A, et al. Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses. J Virol. 2001;75(18):8649–59.
Haralambieva E, Rosati S, van Noesel C, Boers E, van Marwijk KM, Schuuring E, et al. Florid granulomatous reaction in Epstein-Barr virus-positive nonendemic Burkitt lymphomas: report of four cases. Am J Surg Pathol. 2004;28(3):379–83.
Frappier L. Role of EBNA1 in NPC tumourigenesis. Semin Cancer Biol. 2012;22(2):154–61. https://doi.org/10.1016/j.semcancer.2011.12.002.
Pavic M, Debourdeau P, Vacelet V, Rousset H. Sarcoidosis and sarcoid reactions in cancer. Rev Med Interne. 2008;29(1):39–45. https://doi.org/10.1016/j.revmed.2007.09.041.
Looi LM. The pattern of amyloidosis in a Malaysian patient population. Histopathology. 1991;18(2):133–41.
Ueno T, Hoshii Y, Cui D, Kawano H, Gondo T, Takahashi M, et al. Immunohistochemical study of cytokeratins in amyloid deposits associated with squamous cell carcinoma and dysplasia in the oral cavity, pharynx and larynx. Pathol Int. 2003;53(5):265–9.
Tsujikawa T, Kumar S, Borkar RN, Azimi V, Thibault G, Chang YH, et al. Quantitative multiplex immunohistochemistry reveals myeloid-inflamed tumor-immune complexity associated with poor prognosis. Cell Rep. 2017;19(1):203–17. https://doi.org/10.1016/j.celrep.2017.03.037.
The authors thank all the members of the Cancer Center, Chang Gung Memorial Hospital, for their invaluable help.
This study was supported by a grant (MOST105-2628-B-182A-008-MY3) from the Ministry of Science & Technology and a grant (CMRPG2G0231) from Chang Gung Memorial Hospital, Keelung, Taiwan.
Conflict of interest
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Lee, Y., Lee, L., Tsang, N. et al. Prognostic Significance of Granuloma and Amyloid Deposition in Nasopharyngeal Carcinoma. Head and Neck Pathol (2020). https://doi.org/10.1007/s12105-020-01194-4
- Nasopharyngeal carcinoma
- Head and neck